Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
Date:7/31/2012

Income (loss) from operations

7.6(5.1)5.7(16.9)Interest income (expense), net

0.1(0.0)0.3(0.1)Net income (loss)

$ 7.7$ (5.1)$ 6.0$ (17.0)Net income (loss) per common share:Basic

$ 0.16$(0.11)$ 0.12$ (0.36)Diluted

$ 0.16$(0.11)$ 0.12$ (0.36)Shares used to compute net income (loss)per share:Basic

48.647.848.647.8Diluted

49.247.849.347.8*includes the following amountsof stock-based compensation expense:Cost of goods sold

$ 0.0$ 0.0$ 0.0$ 0.0Research and development

0.60.81.21.6Selling, general and administrative

3.23.26.36.7AUXILIUM PHARMACEUTICALS, INC.Table 2 - Selected Consolidated Balance Sheet Data(In millions)(Unaudited)June 30,December 31,20122011Cash and cash equivalents$ 181.3$ 154.3Total assets329.4301.0Total stockholders' equity 107.984.4AUXILIUM PHARMACEUTICALS, INC.Table 3 - 2nd Quarter 2012 Revenue Details(In millions, except for percentages)(Unaudited)Three Months Ended June 30,Incr.Six Months Ended June 30,Incr.20122011 (Decr.)20122011 (Decr.)Testim U.S. Revenue

$62.5$49.726%$120.4$95.226%Testim Ex – U.S. Royalty & Contract Revenue

1.30.862%2.01.443%Total Testim Revenue

$63.8$50.526%$122.4$96.727%XIAFLEX U.S. Revenue

$11.9$9.921%$24.5$18.532%XIAFLEX Revenue Recognition Change

--n/a-1.8n/aXIAFLEX Royalty & Contract Revenue

2.55.5(54%)4.97.3(33%)Total XIAFLEX Revenue

$14.4$15.4(6%)$29.4$27.66%Total Worldwide Revenue

$78.2$65.919%$151.8$124.222%Contract Revenues represent amortization of previously received upfront and milestone payments.AUXILIUM PHARMACEUTICALS, INC.Table 4- 2012 Financial Guidance(Unaudited)PreviousUpdatedTotal Net Revenues

$293 - 315$310 - 332Global Testim Revenues

$225 - 235$245 - 255XIAFLEX:U.S. Revenues$55 - 65$55 - 65Ex U.S. / Contract Rev.$13 - 15$10 - 12Total XIAFLEX

$68 - 80

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
2. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
3. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
4. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
5. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Jason Pharmaceuticals, Inc. Reaches Proposed Consent Agreement with FTC
8. Avion Pharmaceuticals, LLC., Launches Prenate Mini
9. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
11. Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
(Date:12/24/2014)... 24, 2014  Commonwealth Cornerstone Group (CCG) today announced the ... on Tuesday to help fund the expansion and consolidation of ... Sharon . PHN is the ... . It is the largest employer in ... people on staff. Currently, PHN Sharon offers scattered ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
... FARMINGDALE, N.Y., Sept. 29 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, today announced plans to release fourth quarter and ... Thursday afternoon, October 1, 2009. Michael A. McManus, ...
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused ... of a Phase 2b trial for Empatic(TM) on Wednesday, September ... be followed by a live webcast and conference call at ... call and webcast to discuss the results of this clinical ...
Cached Medicine Technology:Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern 2
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 26, 2014 The report “TS-1 (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is an anti-cancer drug which is typically used for ... also used for treating gastric cancer and pancreatic cancer. ... The drug was first approved in 1999 in Japan ...
(Date:12/25/2014)... 2014 The short film “Color of Honor” ... honor of a true 9/11 hero, Welles Remy Crowther. It ... the 24 hours of Nuremberg International Short Film Festival and ... Actress, screenwriter and director Luciana Lagana plays the ... with her husband, Gregory Graham - Graham plays ...
(Date:12/25/2014)... 2014 Recently, LunaDress.co.uk has updated its blog to ... accessories. Now, all of the models at LunaDress.co.uk come with big ... lifts the wedding veil can turn out to be a most ... wedding veil can always bring surprise to a wedding. On the ... to choose veils for a big day . , Going ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... on a "fountain of youth" drug that can delay the ... a new study suggests. Seniors received a significant boost ... a genetic signaling pathway linked to aging and immune function, ... The experimental medication, a version of the drug rapamycin, improved ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3
... , , ... Intelligence Associates, Inc. (BIA), an information management industry leader, ... of scalable, multi-language document repositories for electronic discovery and ... affordable cost shift in the legal document review market ...
... returning from a tryst with his Argentine mistress last June, ... "soul mate." His choice of words seemed to suggest that ... Chapur somehow made his sexual infidelity to his wife Jenny ... is that most women view emotional infidelity as worse, not ...
... ... ... Convention (USP) will convene a meeting of its member organizations on April 21–24 in ... pressing global and domestic public health issues. Known for its large and distinguished international ...
... brain function a serious concern, researchers say , TUESDAY, Jan. 26 ... infected with the virus that causes AIDS, new research suggests. , ... it -- or both -- are contributing to the aging. But ... about the same as in those of uninfected people who are ...
... ... daily workflow for safer, more effective patient care , ... San Mateo, Calif. (PRWEB) January 26, 2010 -- Epocrates, Inc., ... its enterprise use by health systems, hospitals and universities nationwide in 2009. The market demand ...
... double time to disease progression, study finds , ... cancer patients with the drug pazopanib (Votrient) slowed their ... found. , The phase 3 study included 233 patients ... cell carcinoma) that was locally advanced or had spread, ...
Cached Medicine News:Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 2Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 3Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 4Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 5Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 6Health News:His or hers jealousy? Study offers new explanation for sex differences in jealousy 2Health News:Public Health in Focus at International Conference 2Health News:Public Health in Focus at International Conference 3Health News:Premature Aging of the Brain Seen in HIV Patients 2Health News:Health Systems, Hospitals and Universities Nationwide Chose Epocrates in 2009 for Trusted Point-of-Care Clinical Information 2Health News:Health Systems, Hospitals and Universities Nationwide Chose Epocrates in 2009 for Trusted Point-of-Care Clinical Information 3Health News:New Drug Slows Advanced Kidney Cancer 2
High temp cauteries, fine tip micro....
Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....
6 mm, 45 degree upwards, detachable....
Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions....
Medicine Products: